These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 18686863)

  • 21. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
    Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
    Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of orlistat on cardiovascular disease risk in obese adults.
    Swinburn BA; Carey D; Hills AP; Hooper M; Marks S; Proietto J; Strauss BJ; Sullivan D; Welborn TA; Caterson ID
    Diabetes Obes Metab; 2005 May; 7(3):254-62. PubMed ID: 15811142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risk factors for cerebrovascular stroke in a cohort of hypertensive patients].
    Rocha E; Gouveia-Oliveira A; Cotter A; Laranjeiro A; Sousa A; Mendes F; Teixeira H; Galvão J; Miguel JM
    Rev Port Cardiol; 1997 Jun; 16(6):543-56, 508. PubMed ID: 9303608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardioembolic infarction: clinical course and characteristics].
    Santos-Lasaosa S; Navas I; Mostacero E; López del Val J; Tejero C; Escalza I
    Rev Neurol; 2000 Dec 16-31; 31(12):1154-8. PubMed ID: 11205549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
    Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
    Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic interventions and success in risk factor control for secondary prevention of stroke.
    Alvarez-Sabin J; Quintana M; Hernandez-Presa MA; Alvarez C; Chaves J; Ribo M
    J Stroke Cerebrovasc Dis; 2009; 18(6):460-5. PubMed ID: 19900649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukoaraiosis and lacunar infarcts in ischemic stroke: role of age and vascular risk factors.
    Le Pira F; Giuffrida S; Giammona G; Saponara R; Lanza S; La Spina V
    Ann Ital Med Int; 1997; 12(2):72-5. PubMed ID: 9284598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ischemic stroke in patients with primary brain tumors.
    Kreisl TN; Toothaker T; Karimi S; DeAngelis LM
    Neurology; 2008 Jun; 70(24):2314-20. PubMed ID: 18541885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with recurrent coronary events among patients with cardiovascular disease.
    McConnell KJ; Olson KL; Delate T; Merenich JA;
    Pharmacotherapy; 2009 Aug; 29(8):906-13. PubMed ID: 19637943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in risk factors, patterns and causes in hospitalized strokes over 25 years: The Lausanne Stroke Registry.
    Carrera E; Maeder-Ingvar M; Rossetti AO; Devuyst G; Bogousslavsky J;
    Cerebrovasc Dis; 2007; 24(1):97-103. PubMed ID: 17519551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiating ischemic stroke subtypes: risk factors and secondary prevention.
    Kirshner HS
    J Neurol Sci; 2009 Apr; 279(1-2):1-8. PubMed ID: 19185319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective review of the medical records of cardiology hospital outpatient clinics with the aim of determining the therapeutic approach to patients suffering from high blood pressure and/or dyslipidemia.
    Rato Q; Cardoso AA
    Rev Port Cardiol; 2006 Oct; 25(10):889-905. PubMed ID: 17190239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mycoses of the central nervous system].
    Gerhard L; Hugo HH
    Mycoses; 1991; 34 Suppl 1():21-4. PubMed ID: 1818256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of neurological disease in later life.
    Rudd AG; Wolfe CD; Howard RS
    J Neurol Neurosurg Psychiatry; 1997 Nov; 63 Suppl 1(Suppl 1):S39-52. PubMed ID: 9408128
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of alcohol-related brain damage.
    Drew LR
    Med J Aust; 1980 Jul; 2(1):48. PubMed ID: 7432275
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary prevention of neurological illness early in life.
    Clarke A
    J Neurol Neurosurg Psychiatry; 1997 Nov; 63 Suppl 1(Suppl 1):S24-33. PubMed ID: 9408126
    [No Abstract]   [Full Text] [Related]  

  • 39. [Influence of major risk factors on the secondary prevention of brain vessel disease].
    Wang W; Zhang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Feb; 29(2):185-7. PubMed ID: 18686863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.